ALMOTRIPTAN (ALMOTRIPTAN MALATE) — all Canadian products
15 DINs
10 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ALMOTRIPTAN (ALMOTRIPTAN MALATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02570289 | AG-ALMOTRIPTAN | ANGITA PHARMA INC. | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MG | Approved | |
| 02570297 | AG-ALMOTRIPTAN | ANGITA PHARMA INC. | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Approved | |
| 02424029 | ALMOTRIPTAN | PRO DOC LIMITEE | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Marketed | |
| 02466821 | ALMOTRIPTAN | SANIS HEALTH INC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Marketed | |
| 02556022 | JAMP ALMOTRIPTAN | JAMP PHARMA CORPORATION | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MG | Approved | |
| 02556030 | JAMP ALMOTRIPTAN | JAMP PHARMA CORPORATION | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Approved | |
| 02398443 | MYLAN-ALMOTRIPTAN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Marketed | |
| 02398435 | MYLAN-ALMOTRIPTAN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MG | Marketed | |
| 02405334 | SANDOZ ALMOTRIPTAN | SANDOZ CANADA INCORPORATED | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Marketed | |
| 02434849 | TEVA-ALMOTRIPTAN | TEVA CANADA LIMITED | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Marketed | |
| 02405806 | APO-ALMOTRIPTAN | APOTEX INC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Dormant | |
| 02405792 | APO-ALMOTRIPTAN | APOTEX INC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MG | Dormant | |
| 02248129 | AXERT 12.5MG | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Cancelled Post Market | |
| 02248128 | AXERT 6.25MG | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MG | Cancelled Post Market | |
| 02441411 | PMS-ALMOTRIPTAN | PHARMASCIENCE INC | Tablet | Oral | ALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MG | Cancelled Pre Market |
Browse other molecules: